Feb 20, 2015 12:37pm EST OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test
Feb 13, 2015 12:13pm EST OPKO Health to Present at the 2015 RBC Capital Markets’ Healthcare Conference
Jan 30, 2015 11:58am EST OPKO Submits Investigational New Drug Application to Initiate a Phase 2a Trial for its Long-Acting Coagulation Factor VIIa-CTP to Treat Hemophilia
Jan 13, 2015 11:49am EST OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno Technologies NIH Grant
Nov 10, 2014 8:37am EST OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States